Scientific publications on lymphomas

Home > Scientific publications on lymphomas

The results and conclusions of the work conducted by the Lymphoma Research Experts ecosystem are published in leading medical journals.

Lysa 2023_LYSA_Randomized Phase III Trial Evaluating Sub-Cutaneous Rituximab for the First Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
Guillaume Cartron, Emmanuel Bachy, Hervé Tilly, Nicolas Daguindau, Gian-Matteo Pica, Fontanet Bijou, Christiane Mounier, Aline Clavert, Gandhi Laurent Damaj, Borhane Slama, Olivier Casasnovas, Roch Houot, Krimo Bouabdallah, David Sibon, Olivier Fitoussi, Nadine Morineau, Charles Herbaux, Thomas Gastinne, Luc- Matthieu Fornecker, Corinne Haioun, Vincent Launay, Carla Araujo, Omar Benbrahim, Laurence Sanhes, Remy Gressin, Hugo Gonzalez, Franck Morschhauser, David Ternant, Luc Xerri, Karin Tarte, Delphine Pranger
J Clin Oncol . 2023 Apr 18;JCO2202327. doi: 10.1200/JCO.22.02327. Learn more
Lysa 2022_LYSA_Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials
Sidsel J Juul, Sára Rossetti, Michal Kicinski, Marleen A E van der Kaaij, Francesco Giusti, Paul Meijnders, Berthe M P Aleman, John M M Raemaekers, Hanneke C Kluin-Nelemans, Michele Spina, Christophe Fermé, Loïc Renaud, Olivier Casasnovas, Aspasia Stamatoullas, Marc André, Fabien Le Bras, Wouter J Plattel, Michel Henry-Amar, Martin Hutchings, Maja V Maraldo
DOI: 10.1007/s11764-022-01305-w Learn more
Lysa 2023_LYSA_High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
Olivier Hermine, Linmiao Jiang, Jan Walewski, André Bosly, Catherine Thieblemont, Michal Szymczyk, Christiane Pott, Gilles Salles, Pierre Feugier, Kai Hübel, Corinne Haioun, René Olivier Casasnovas, Christian Schmidt, Kamal Bouabdallah, Vincent Ribrag, Lothar Kanz, Jan Dürig, Bernd Metzner, David Sibon, Morgane Cheminant, Barbara Burroni, Wolfram Klapper, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Martin Dreyling, European Mantle Cell Lymphoma Network
DOI: 10.1200/JCO.22.01780 Learn more
Lysa 2023_LYSA_Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome
Luis Veloza, Doriane Cavalieri, Edoardo Missiaglia, Albane Ledoux-Pilon, Bettina Bisig, Bruno Pereira, Christophe Bonnet, Elsa Poullot, Leticia Quintanilla-Martinez, Romain Dubois, Francisco Llamas-Gutierrez, Céline Bossard, Roland De Wind, Fanny Drieux, Juliette Fontaine, Marie Parrens, Jeremy Sandrini, Virginie Fataccioli, Marie-Hélène Delfau-Larue, Adrien Daniel, Faustine Lhomme, Lauriane Clément-Filliatre, François Lemonnier, Anne Cairoli, Pierre Morel, Sylvie Glaisner, Bertrand Joly, Abderrazak El Yamani, Kamel Laribi, Emmanuel Bachy, Reiner Siebert, David Vallois, Philippe Gaulard, Olivier Tournilhac, Laurence De Leval
DOI: 10.3324/haematol.2022.281226 Learn more
Lysa 2023_LYSA_Central nervous system relapse in younger patients with diffuse large B-cell lymphoma – a LYSA and GLA/ DSHNHL analysis
Catherine Thieblemont, Bettina Altmann, Fabian Frontzek, Loic Renaud, Loic Chartier, Nicolas Ketterer, Christian Recher, Viola Poeschel, Olivier Fitoussi, Gerhard Held, Olivier Casasnovas, Corinne Haioun, Franck Morschhauser, Bertram Glass, Nicolas Mounier, Herve Tilly, Andreas Rosenwald, German Ott, Georg Lenz, Thierry Molina, Marita Ziepert, Norbert Schmitz
doi: 10.1182/bloodadvances.2022008888. Learn more
Lysa 2022_LYSA_From Stem Cell Transplantation to CAR-T Therapy in Relapse-Refractory Diffuse Large B-Cell Lymphoma
Christian Gisselbrecht, Eric Van Den Neste
doi.org/10.18103/mra.v10i8.3014 Learn more
Lysa 2022_LYSA_Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?
Christian Gisselbrecht, David Sibon
doi: 10.1111/bjh.18468 Learn more
Lysa 2022_LYSA_Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy. A DESCAR-T analysis
Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, René-Olivier Casanovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
doi: 10.1182/blood.2022016945. Learn more
Calym HemSys_Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase
Lise-Marie Mollard, Aurélie Chauveau, Françoise Boyer-Perrard, Nathalie Douet-Guilbert, Roch Houot, Isabelle Quintin-Roué, Marie-Anne Couturier, Anaig Dagorne, Mohamed Malou, Ronan Le Calloch, Odile Luycx, Sylvain Thepot, Mathilde Hunault, Gaelle Guillerm, Christian Berthou, Valérie Ugo, Éric Lippert & Jean-Christophe Ianotto
Leukemia & Lymphoma, 59:12, 2812-2820, DOI: 10.1080/10428194.2018.1441408 Learn more
Calym HemSys_IGHV segment utilization in immunoglobulin gene rearrangement differentiates patients with anti-myelin-associated glycoprotein neuropathy from others immunoglobulin M-gammopathies
Jean-Sebastien Allain, Florian Thonier, Morgane Pihan, Marie-Laure Boulland, Sophie de Guibert, Vincent Launay, Anne-Violaine Doncker, Michel Ganard, Amyra Aliouat, Céline Pangault, Roch Houot, Marie De Tayrac, Thierry Lamy, Mikael Roussel, Thierry Fest, Olivier Decaux, Cedric Pastoret
Haematologica 2018;103(5):e207-e210; https://doi.org/10.3324/haematol.2017.177444. Learn more
Calym HemSys_Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome
L. Alix, A. Néel, B. Cador, A. Smail, J. Serratrice, F. Closs-Prophette, P. Jego, A. Devillers & O. Decaux
Autoimmunity, 52:7-8, 264-271, DOI: 10.1080/08916934.2019.1680649 Learn more
Calym HemSys_Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)
Durot, E., Tomowiak, C., Michallet, A.-S., Dupuis, J., Hivert, B., Leprêtre, S., Toussaint, E., Godet, S., Merabet, F., Van Den Neste, E., Ivanoff, S., Roussel, X., Zini, J.-M., Regny, C., Lemal, R., Sutton, L., Perrot, A., Le Dû, K., Kanagaratnam, L., Morel, P., Leblond, V. and Delmer, A.
Br J Haematol, 179: 439-448. https://doi.org/10.1111/bjh.14881 Learn more
HemSys_Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study
Reboursiere E., Bras F., Herbaux C., Gyan E., Clavert A., Morschhauser F., Malak S., Sibon D., Broussais F., Braun T., Fornecker L., Garidi R., Tricot S., et al
Oncotarget. 2016; 7: 85573-85583. Retrieved from https://www.oncotarget.com/article/10764/text/ Learn more
Calym HemSys_Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life
Norwood, J., Pastoret, C., Luycx, O., Le Coz, M.-F., Moreau, P., Trebouet, A., Niault, M., Launay, V., Allangba, O., Bareau, B., Doncker, V., Grulois, I., Jacomy, D., Le Dû, K., Henry, C., Le Pabic, E., Boulland, M.-L., Fest, T., Lamy, T. and Escoffre-Barbe, M.
Am J Hematol, 93: E329-E331. https://doi.org/10.1002/ajh.25217 Learn more
Calym HemSys_Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement
Mercier M, Orvain C, Drieu La Rochelle L, Marchand T, Nunes Gomes C, Giltat A, Paillassa J, Clavert A, Farhi J, Rousselet M-C, Gyan E, Houot R, Moles-Moreau M-P, Hunault-Berger M.
Cancers 2021, 13(12), 2945; https://doi.org/10.3390/cancers13122945 Learn more
Calym HemSys_Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Sophie Langner-Lemercier, Caroline Houillier, Carole Soussain, Hervé Ghesquières, Olivier Chinot, Luc Taillandier, Pierre Soubeyran, Thierry Lamy, Franck Morschhauser, Alexandra Benouaich-Amiel, Guido Ahle, Marie-Pierre Moles-Moreau, Cécile Moluçon-Chabrot, Pascal Bourquard, Ghandi Damaj, Fabrice Jardin, Delphine Larrieu, Emmanuel Gyan, Remy Gressin, Arnaud Jaccard, Sylvain Choquet, Annie Brion, Olivier Casasnovas, Philippe Colin, Oumedaly Reman, Adrian Tempescul, Jean-Pierre Marolleau, Michel Fabbro, Florian Naudet, Khê Hoang-Xuan, Roch Houot
Neuro-Oncology, Volume 18, Issue 9, September 2016, Pages 1297–1303, https://doi.org/10.1093/neuonc/now033 Learn more
Calym HemSys_Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study
Isabelle Fleury, Sandy Amorim, Nicolas Mounier, Bertrand Coiffier, Jehan Dupuis, Hervè Tilly, Mohamed A. Mazari, Lauriane Filliatre, Josette Brière, Pauline Brice, Eric de Kerviler & Catherine Thieblemont
Leukemia & Lymphoma, 56:7, 2025-2031, DOI: 10.3109/10428194.2014.977884 Learn more
Lysa 2022_LYSA_A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Manson, Guillaume Cartron, David Beauvais, Louise Roulin, François Xavier Gros, Marie Thérèse Rubio, Pierre Bories, Jacques Olivier Bay, Cristina Castilla Llorente, Sylvain Choquet, René-Olivier Casasnovas, Mohamad Mohty, Stéphanie Guidez, Magalie Joris, Michaël Loschi, Sylvain Carras, Julie Abraham, Adrien Chauchet, Laurianne Drieu La Rochelle, Bénédicte Deau-Fischer, Olivier Hermine, Thomas Gastinne, Jean Jacques Tudesq, Elodie Gat, Florence Broussais, Catherine Thieblemont, Roch Houot & Franck Morschhauser
doi: 10.1038/s41591-022-01969-y. Learn more
Lysa 2022_LYSA_PET-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T-cells
Jean Galtier, Laetitia Vercellino, Loic Chartier, Pierre Olivier, Claire Tabouret-Viaud, Charles Mesguich, Roberta Di Blasi, Amandine Durand, Léo Raffy, François-Xavier Gros, Isabelle Madelaine, Veronique Meignin, Miryam Mebarki, Marie-Thérèse Rubio, Pierre Feugier, Olivier Casasnovas, Michel Meignan, Catherine Thieblemont
doi: 10.3324/haematol.2021.280550. Learn more
Lysa 2022_LYSA_Interpretation of 2-[ 18 F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors
Manson G, Lemchukwu AC, Mokrane FZ, Lopci E, Aide N, Vercellino L, Houot R, Dercle L.
Eur Radiol . 2022 Sep;32(9):6536-6544. Learn more
Lysa 2022_LYSA_Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations
Nicolae A, Bouilly J, Lara D, Fataccioli V, Lemonnier F, Drieux F, Parrens M, Robe C, Poullot E, Bisig B, Bossard C, Letourneau A, Missiaglia E, Bonnet C, Szablewski V, Traverse-Glehen A, Delfau-Larue MH, de Leval L, Gaulard P
Mod Pathol . 2022 Aug;35(8):1126-1136. Learn more
Lysa 2022_LYSA_Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)
Manson G, Herbaux C, Schiano JM, Casasnovas O, Stamatoullas A, Deau B, Schmitt A, Regny C, Bouabdallah K, Chauchet A, Ghesquieres H, Tempescul A, Dulery R, Nicolas-Virelizier E, Delmer A, Borel C, Dercle L, Brice P, Houot R; Lymphoma Study Association (LYSA).
Br J Haematol . 2022 Jul;198(1):203-206. Learn more
Lysa 2022_LYSA_Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
Amira Marouf, Anne-Ségolène Cottereau, Salim Kanoun, Paul Deschamps, Michel Meignan, Patricia Franchi, David Sibon, Clara Antoine, Thomas Gastine, Cecile Borel, Mohammad Hammoud, Guillaume Sicard, Romane Gille, Doriane Cavalieri, Aspasia Stamatoullas, Lauriane Filliatre-Clement, Julien Lazarovici, Adrien Chauchet, Luc-Matthieu Fornecker, Sandy Amorin, Mathieu Rocquet, Nicolae Raus, Barbara urroni, Marie-Thérèse Rubio, Didier Bouscary, Pilippe Quittet, René-Olivier Casanovas, Pauline Brice, Hervé Guesquieres, Jerome Tamburini, Benedicte Deau
Haematologica . 2022 Jul 1;107(7):1681-1686. Learn more
Lysa 2022_LYSA_Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with Mantle Cell lymphoma, a LYSA retrospective study
Domitille Costes-Tertrais, Thomas Hueso, Thomas Gastinne, Catherine Thieblemont, Lucie Oberic, Krimo Bouabdallah, Sylvain Garciaz, Emmanuelle Tchernonog, Caroline Dartigeas, vincent ribrag, Patrick Fogarty, René-Olivier Casasnovas, Roch Houot, Caroline Delette, Sandra Malak, Luc-Matthieu Fornecker, Remy Gressin, Gandhi Damaj, and Steven Le Gouill
Bone Marrow Transplant . 2022 Apr;57(4):627-632. Learn more